• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

早期乳腺癌的最佳辅助化疗和靶向治疗——细胞周期蛋白依赖性激酶 4 和 6 抑制剂：ASCO 指南快速推荐更新。

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.

机构信息

Dana-Farber Cancer Institute, Boston, MA.

Stanford University School of Medicine, Stanford, CA.

出版信息

J Clin Oncol. 2024 Jun 20;42(18):2233-2235. doi: 10.1200/JCO.24.00886. Epub 2024 May 20.

DOI:10.1200/JCO.24.00886
PMID:38768407
Abstract

.

摘要

.

相似文献

1
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.早期乳腺癌的最佳辅助化疗和靶向治疗——细胞周期蛋白依赖性激酶 4 和 6 抑制剂：ASCO 指南快速推荐更新。
J Clin Oncol. 2024 Jun 20;42(18):2233-2235. doi: 10.1200/JCO.24.00886. Epub 2024 May 20.
2
Systemic Therapy Update on Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Update.镥-PSMA-617用于转移性去势抵抗性前列腺癌的系统治疗更新：美国临床肿瘤学会指南快速推荐更新
J Clin Oncol. 2024 Nov;42(31):3751-3752. doi: 10.1200/JCO.23.02128. Epub 2023 Nov 6.
3
Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update.激素受体阳性、人表皮生长因子受体 2 阴性转移性乳腺癌的内分泌和靶向治疗-卡培他滨-氟维司群：ASCO 快速推荐更新。
J Clin Oncol. 2024 Apr 20;42(12):1450-1453. doi: 10.1200/JCO.24.00248. Epub 2024 Mar 13.
4
Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.Ⅲ期非小细胞肺癌的治疗管理：ASCO 指南快速推荐更新。
J Clin Oncol. 2024 Sep 1;42(25):3058-3060. doi: 10.1200/JCO-24-01324. Epub 2024 Jul 23.
5
Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update.阿贝西利联合内分泌治疗用于高危早期乳腺癌的治疗：美国临床肿瘤学会最佳辅助化疗和靶向治疗指南快速推荐更新
J Clin Oncol. 2022 Jan 20;40(3):307-309. doi: 10.1200/JCO.21.02677. Epub 2021 Dec 8.
6
Cancer Cachexia: ASCO Guideline Rapid Recommendation Update.癌症恶病质：美国临床肿瘤学会指南快速推荐更新
J Clin Oncol. 2023 Sep 1;41(25):4178-4179. doi: 10.1200/JCO.23.01280. Epub 2023 Jul 12.
7
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update.内分泌治疗后或激素受体阴性转移性乳腺癌的化疗与靶向治疗：美国临床肿瘤学会指南快速推荐更新
J Clin Oncol. 2023 Feb 20;41(6):1318-1320. doi: 10.1200/JCO.22.02807. Epub 2023 Jan 10.
8
Testing for Mutations to Guide Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update.检测突变以指导激素受体阳性、人表皮生长因子受体 2 阴性转移性乳腺癌的治疗：ASCO 指南快速推荐更新。
J Clin Oncol. 2023 Jun 20;41(18):3423-3425. doi: 10.1200/JCO.23.00638. Epub 2023 May 17.
9
Management of Metastatic Renal Clear Cell Cancer: ASCO Guideline Rapid Recommendation Update.转移性肾透明细胞癌的管理：美国临床肿瘤学会指南快速推荐更新
J Clin Oncol. 2023 Nov 20;41(33):5184-5186. doi: 10.1200/JCO.23.01977. Epub 2023 Oct 9.
10
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.Ⅲ期非小细胞肺癌的管理：美国临床肿瘤学会指南快速推荐更新
J Clin Oncol. 2023 Sep 20;41(27):4430-4432. doi: 10.1200/JCO.23.01261. Epub 2023 Jul 20.

引用本文的文献

1
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.加拿大HR阳性、HER2阴性早期乳腺癌患者辅助性CDK4/6抑制剂应用的多学科实践指南
Curr Oncol. 2025 Aug 7;32(8):444. doi: 10.3390/curroncol32080444.
2
Comparing the diagnostic efficacy of [F]FDG PET/CT and [F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis.比较[F]FDG PET/CT与[F]FDG PET/MRI对乳腺癌复发的诊断效能：一项系统评价与Meta分析。
Front Med (Lausanne). 2025 Aug 1;12:1602415. doi: 10.3389/fmed.2025.1602415. eCollection 2025.
3
Tumor-microenvironment triggered Mn-Gd based nanosystem for breast carcinoma suppression via synergistic radiotherapy and glutathione-depleting along with glucose oxidase combination enhanced Ros storm.
肿瘤微环境触发的基于锰-钆的纳米系统，通过协同放疗、消耗谷胱甘肽以及结合葡萄糖氧化酶增强活性氧爆发来抑制乳腺癌。
J Nanobiotechnology. 2025 Aug 11;23(1):557. doi: 10.1186/s12951-025-03636-z.
4
Predicting pathologic ≥N2 disease in women with breast cancer.预测乳腺癌女性患者的病理分期≥N2疾病
NPJ Breast Cancer. 2025 May 22;11(1):46. doi: 10.1038/s41523-025-00757-4.
5
Survival outcomes in trial defined high-risk hormone receptor-positive/human epidermal growth factor receptor II-negative early breast cancer: impact of adjuvant chemotherapy.试验定义的高危激素受体阳性/人表皮生长因子受体II阴性早期乳腺癌的生存结果：辅助化疗的影响
Discov Oncol. 2025 May 16;16(1):783. doi: 10.1007/s12672-025-02601-4.
6
Extended endocrine therapy use and decision making after breast cancer diagnosis.乳腺癌诊断后的延长内分泌治疗应用与决策制定。
J Natl Cancer Inst. 2025 Aug 1;117(8):1573-1582. doi: 10.1093/jnci/djaf076.
7
Clinician's guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer.临床医生指南：早期乳腺癌患者使用CDK4/6抑制剂的专家见解
Ther Adv Med Oncol. 2025 Mar 20;17:17588359251326710. doi: 10.1177/17588359251326710. eCollection 2025.
8
Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2-ve Early Breast Cancer (EBC).细胞周期蛋白依赖性激酶（CDK）4/6抑制剂用于激素受体阳性（HR+ve）、人表皮生长因子受体2阴性（Her2-ve）早期乳腺癌（EBC）管理的共识指南
South Asian J Cancer. 2024 Nov 18;14(1):45-52. doi: 10.1055/s-0044-1791768. eCollection 2025 Jan.
9
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial.新辅助纳武单抗与化疗用于早期雌激素受体阳性乳腺癌：一项随机3期试验
Nat Med. 2025 Feb;31(2):433-441. doi: 10.1038/s41591-024-03414-8. Epub 2025 Jan 21.
10
ChatGPT's Agreement with the Recommendations from the 18th St. Gallen International Consensus Conference on the Treatment of Early Breast Cancer.ChatGPT与第18届圣加仑国际早期乳腺癌治疗共识会议建议的一致性。
Cancers (Basel). 2024 Dec 13;16(24):4163. doi: 10.3390/cancers16244163.